http://www.spectraintelligence.com/nanodrugs.htm

Arrowhead–Spectra’s 1st International Conference on Nanodrugs and Clinical Nanotechnology provides an unmissable forum to learn the challenges and advances of pioneers in nanodrug development and the nanotechnologies applied to medical therapies. Case studies of pipelines, progress and clinical efficacy, and challenges of bioengineering and manufacturing will be the main themes of the conference.

Nanotechnology has the potential to revolutionize medical treatments and medical practice. With hundreds of nanodrugs in development globally, the opportunities for clinical and market successes are apparent. Nanodrugs are at the forefront of bioengineering for diseases such as cancer, cardiovascular disease, and age-related conditions and represent the next generation of medical therapies that will impact worldwide markets, healthcare, and industry.

Arrowhead–Spectra’s 1st International Conference on Nanodrugs and Clinical Nanotechnology provides an unmissable forum to learn the challenges and advances of pioneers in nanodrug development and the nanotechnologies applied to medical therapies. Case studies of pipelines, progress and clinical efficacy, and challenges of bioengineering and manufacturing will be the main themes of the conference.

WHY ATTEND:
* Learn the latest developments in nanodrug development and clinical nanotechnology;
* Better understand the trends of nanodrug development;
* Learn from experts on the challenges and the solutions to bioengineering and manufacturing;
* Determine the efficacy of clinical stage nanodrug products;
* Establish the next generation market leaders in cancer and other therapy areas;
* Network with leaders from nanotechnology, pharma-biotech and healthcare industries

London, United Kingdom
Contact: Tim Atkinson, Arrowhead-Spectra Conferences
44 (0) 208 671 7726